
Commodity markets have become the backbone of global trade and investment strategies. Whether you're a beginner or an active trader on MCX, commodities like Gold, Silver, Crude Oil, Natural Gas, and Copper play a crucial role due to rising volatility, geopolitical tensions, inflation cycles, and changing industrial demand.
In India, commodities are traded primarily through MCX (Multi Commodity Exchange) under SEBI regulations, ensuring transparency and investor protection.
Let’s explore the Top 5 Most Traded Commodities in 2025, their importance, what influences their prices, and how traders can benefit using insights from brokers like Swastika Investmart.
Gold remains the world’s most traded and most preferred safe-haven commodity.
In India, demand is driven by jewellery, central bank buying, inflation hedging, and festive seasons.
Silver is unique because it is both a precious metal and an industrial metal.
In 2025, it’s heavily influenced by demand from EVs, solar panels, electronics, and renewable energy projects.
Crude Oil impacts transportation, manufacturing, inflation, and currency values.
It is the backbone of global energy markets and one of the most traded assets on MCX.
Natural Gas is one of the most volatile commodities, perfect for experienced traders.
Copper is widely used in infrastructure, electrical networks, real estate, EVs, and manufacturing.
Its price is a leading indicator of economic health.
Commodity Snapshot Table
| Commodity | Category | Main Uses | Volatility Level |
|---|---|---|---|
| Gold | Precious Metal | Jewellery, investment, central banks | Low–Medium |
| Silver | Precious + Industrial | Electronics, solar, jewellery | Medium–High |
| Crude Oil | Energy | Transportation, manufacturing, chemicals | High |
| Natural Gas | Energy | Power plants, heating, industrial use | Very High |
| Copper | Base Metal | Electrical, construction, EVs | Medium |
SEBI regulates commodity markets to ensure transparency and fairness:
This makes India’s commodity market stable for both beginners and advanced traders.
Swastika Investmart stands out with:
Whether you're trading intraday crude oil, investing in gold hedging, or tracking copper trends, Swastika provides tools and research for smarter decisions.
Gold and Copper are relatively stable and easier to analyze.
Because its supply depends on geopolitics and global demand cycles.
Yes, due to leverage and volatility always trade with stop loss and regulated brokers.
Depends on lot size and contract value on MCX; smaller mini contracts are available.
Yes Swastika offers MCX trading, research-based calls, and AI market insights for all major commodities.
The top 5 most traded commodities Gold, Silver, Crude Oil, Natural Gas, and Copper continue to dominate global and Indian markets in 2025.
Understanding their price drivers, volatility, and trading patterns helps traders make informed decisions. With SEBI-regulated platforms and AI-powered tools from Swastika Investmart, navigating commodity markets becomes significantly easier and more efficient.
.png)
Vedanta Ltd, one of India’s most diversified natural-resources companies with stakes across aluminium, oil & gas, power, steel, and base metals, has embarked on a bold demerger plan. The idea? To spin off its business verticals into specialized listed entities, unlocking value, improving operational focus, and making each business more investable.
Anil Agarwal, Vedanta’s chairman, has called this a “3D” strategy. Demerger, Diversification, and Deleveraging to double the size of Vedanta. The demerger is not just financial housekeeping; it's a long-term play to let each business chart its own course, raise capital independently, and attract investors with very different risk appetites.
Originally, Vedanta proposed a six-way split. But after revising the plan, it now aims for five demerged companies:
Each shareholder will get one additional share in each of the four new companies (i.e., in addition to their existing Vedanta shares).
Q1: When will the demerger actually complete?
A1: Vedanta has extended its demerger timeline to March 31, 2026, because it is still waiting for NCLT approval and approvals from various government bodies.
Q2: How many shares will I get in the new companies?
A2: According to the demerger scheme, every existing Vedanta shareholder will receive 1 share in each of the four newly demerged companies on completion.
Q3: What are the major risks for shareholders?
A3: Key risks include regulatory delays, possible financial stress in demerged units (e.g., the government has flagged Malco Energy’s viability), and loss of cross-business support once splitting occurs.
Q4: Why did Vedanta drop its base metals demerger plan?
A4: Vedanta revised its earlier 6-way demerger plan and decided not to demerge base metals for now. They may consider it later when the business matures further.
Q5: How can I monitor the progress of the demerger?
A5: Keep an eye on Vedanta’s stock-exchange filings (e.g., BSE/NSE announcements), NCLT updates, and trusted financial news portals. You can also consult your broker’s research tools for detailed corporate-action tracking.
Vedanta’s 2025 demerger is a landmark restructuring, aimed at unlocking hidden value and giving each business vertical enough room to grow independently. For shareholders, it presents both an exciting opportunity (more control, potential re-rating) and real risks (regulatory delays, financing issues).
If you're an investor looking to navigate this transformation, having a reliable broker is key. That’s where Swastika Investmart comes in: SEBI-registered, backed by strong research tools, tech-enabled investing platforms, and a deep commitment to investor education and support.
Ready to act?
👉 Open your account with Swastika Investmart today
today and stay ahead as Vedanta writes its next chapter.

Kotak Mahindra Bank has announced a 1:5 share split, making it one of the biggest corporate actions in the Indian banking sector for 2025. As one of India’s most respected private-sector banks, Kotak’s decision has drawn strong interest from both long-term investors and short-term traders.
But what does this share split really mean for your portfolio? Does it create value, or is it simply a psychological boost? This detailed guide breaks down the implications, market context, and what smart investors should consider before the ex-split date.
A share split increases the number of outstanding shares by reducing the face value of each share. The move doesn’t change the company’s market capitalization or the value of an investor’s holdings immediately.
Here’s what happens in a 1:5 split:
The primary reasons companies pursue share splits include:
Indian companies usually announce splits when their share prices have risen significantly over time, making the stock relatively expensive compared to peers.
Kotak Mahindra Bank has traditionally traded at a premium to many bank stocks due to its strong asset quality, prudent lending practices, and robust CASA franchise. After years of consistent growth, its stock price became relatively high, making it less accessible to small investors.
The split aligns with three key objectives:
Additionally, with the banking sector expected to see strong credit growth in 2025–26, the timing could help Kotak position itself for broader market participation.
Let’s take a simple scenario.
Before the split:
After the split:
Your wealth does not change immediately. But the stock becomes more accessible to retail investors who may have previously found it expensive.
Share splits often generate excitement, but it’s important to separate perception from reality. Still, splits like Kotak’s tend to have meaningful short-term and long-term effects.
Market analysts believe Kotak’s move aligns with its long-term growth cycle and strengthens its positioning among India’s major private-sector banks.
Corporate actions like share splits must comply with SEBI’s listing norms and disclosure guidelines. Companies must:
Kotak Mahindra Bank’s announcement follows these regulatory norms, contributing to investor confidence.
Not directly. A share split does not increase EPS, book value, net profit, or market cap. It merely divides the existing equity into more units.
However, share splits may:
The real value creation still depends on the bank’s financial performance, credit growth, margins, and risk management.
A split is not a sign of superior performance. Fundamentals matter more.
Kotak’s digital push, capital efficiency, and strong risk controls remain central to its story.
Around the ex-split date, trading activity tends to spike.
There are no special tax benefits for share splits. Capital gains are taxed as usual based on the holding period.
Liquidity improvements can help both traders and long-term investors.
Corporate actions often encourage new investors to enter the market. For those navigating such events, having access to a robust research-driven investment platform makes a significant difference.
This is where Swastika Investmart, a SEBI-registered brokerage, stands out with:
To participate in upcoming opportunities and build a disciplined investment approach, you can open an account easily here:
👉 Open your account with Swastika Investmart today
No. The split only increases the number of shares while reducing the price proportionately. Your total investment value remains unchanged immediately.
It can be beneficial indirectly by improving liquidity and accessibility, but long-term returns depend on the bank’s financial performance.
You will not be eligible for the split. Only shareholders before the ex-date receive additional shares.
No. Taxation works as usual based on capital gains when you sell your shares.
Primarily to make stocks more affordable, boost liquidity, and attract wider participation.
Kotak Mahindra Bank’s 1:5 share split is a strategic step that enhances affordability and supports broader participation in one of India’s leading private-sector banks. While the split itself doesn’t add intrinsic value, it can create an environment that supports smoother price discovery and long-term investor engagement.
If you want to navigate such corporate actions with clarity and research-backed tools, Swastika Investmart offers a dependable ecosystem for traders and investors.
Open your Demat & Trading account here and start investing with confidence:
Bonus issues have again taken center stage in the Indian markets as HDFC AMC and Thyrocare Technologies announce generous bonus ratios for November 2025. While these moves have sparked excitement among retail investors, it’s important to look beyond the headline ratios and understand what these bonus issues mean for valuation, liquidity, taxation, and long-term investment decisions.
To help you make an informed choice, here’s a detailed breakdown of both corporate actions, their market context, and what smart investors should keep in mind.
A bonus issue is when a listed company issues additional shares to existing shareholders for free by capitalizing its reserves. This typically improves liquidity and makes the stock price more affordable without affecting the company's underlying fundamentals.
For example, if you hold 50 shares, and the company declares a 1:1 bonus, you will receive 50 additional shares, doubling your share count.
However, the market value of the investment remains broadly the same on the ex-bonus date because the stock price adjusts proportionately.
HDFC AMC’s announcement of a 1:1 bonus issue has drawn attention because it comes at a time when the asset management industry is witnessing record inflows, especially through SIPs and equity-oriented schemes.
Short-term traders may witness:
From a regulatory angle, SEBI mandates transparent disclosures of bonus ratios, record dates, and corporate action timelines. HDFC AMC’s bonus announcement follows these norms, and market analysts expect healthy participation.
Before bonus:
After 1:1 bonus:
No immediate monetary gain — but future growth potential remains intact.
Thyrocare’s 2:1 bonus (two additional shares for each existing one) is more aggressive and usually seen as a signal of strong reserve position and confidence in future earnings visibility.
Thyrocare has been expanding its diagnostics footprint, leveraging rising demand for preventive health checks in India. Increased retail participation could benefit the stock’s long-term price discovery.
Before bonus:
After 2:1 bonus:
Again, no immediate value addition but improved liquidity and psychological affordability may help long-term valuations.
Bonus announcements often generate short-term enthusiasm in the index-heavy segments if large companies are involved. In this case:
Additionally, rising bonus activity is sometimes viewed as a sign of strong corporate balance sheets and improving business confidence across sectors.
However, investors must remember that bonus issues do not improve fundamentals. They simply increase share count and improve liquidity.
A bonus issue does not change the company’s profitability, cash flows, or intrinsic worth.
Prices may fluctuate around the record date as speculative traders enter and exit.
Bonus shares have zero acquisition cost, and taxation depends on the holding period from the date of allotment.
Holding shares before the ex-date is essential to be eligible for the bonus.
A company giving a high bonus ratio is not always a sign of superior performance.
They can be provided the company continues to execute well on earnings, margins, and growth. Bonuses generally:
But the real returns come from earnings growth, not corporate actions.
Bonus issues can attract many new investors looking to capitalize on post-bonus opportunities. This is where research-backed guidance, transparent tools, and reliable trading platforms play an important role.
Platforms like Swastika Investmart, a SEBI-registered brokerage firm, support investors with:
This helps investors avoid hype-driven decisions and stay aligned with fundamentals.
No. Your portfolio value remains nearly the same immediately after the bonus because the stock price adjusts in proportion to the bonus ratio.
A 1:1 bonus gives one extra share for every share held. A 2:1 bonus gives two extra shares for every share held — tripling the share count.
Bonus shares are tax-free upon receipt. Capital gains tax applies only when you sell them, based on the holding period.
Yes. Only shareholders who hold shares before the ex-date set by the company are eligible for bonus allotment.
Not necessarily. They only indicate that the company has sufficient reserves. The company’s financial health still depends on earnings and business metrics.
Bonus issues like those announced by HDFC AMC (1:1) and Thyrocare (2:1) often generate excitement but should be evaluated with a balanced perspective. They improve liquidity and accessibility but do not inherently create new value. Long-term investors should focus on fundamentals, industry trends, and disciplined investing frameworks.
If you’re exploring bonus plays or long-term investment opportunities, a trusted, research-driven platform can make all the difference.
Open your account with Swastika Investmart and start investing with confidence:
.png)
Nvidia’s Q3 fiscal-2026 results were nothing short of spectacular. The company clocked $57.0 billion in revenue, a 22% increase quarter-over-quarter and a massive 62% year-over-year jump.
The data-centre business, which fuels much of Nvidia’s strength, reported $51.2 billion — up 25% sequentially and a whopping 66% YoY.
Earnings per share (diluted) stood at $1.30, beating market expectations. Gross margins remained healthy: ~73.4% on a GAAP basis and ~73.6% on non-GAAP.
Jensen Huang, Nvidia’s CEO, painted a bold picture: “Blackwell sales are off the charts, and cloud GPUs are sold out … We’ve entered the virtuous cycle of AI.”
On the capital return front, Nvidia has distributed $37 billion to shareholders via buybacks and dividends in the first nine months of fiscal 2026, while still retaining $62.2 billion under its repurchase authorization.
Nvidia’s blazing growth is a clear sign that AI infrastructure is scaling up rapidly. For Indian cloud service providers, startups, and large enterprises, this means greater access to powerful compute — and hence more opportunity to build or scale AI-driven products, whether in generative AI, autonomous systems, or large-language-model applications.
IT services companies such as TCS, Infosys, HCL Tech, and Wipro stand to benefit in multiple ways:
India has long expressed ambitions to build a vibrant semiconductor ecosystem. Nvidia’s strong earnings fuel confidence in the global semiconductor demand outlook — which may in turn accelerate semiconductor-related investments in India.
While Nvidia’s results are a vote of confidence in the AI era, Indian investors and companies should also remain aware of potential headwinds:
For Indian investors looking to play the Nvidia or AI-infrastructure story:
Q1. Does Nvidia’s strong result mean an “AI bubble” is safe to ignore?
Not entirely. While Nvidia’s performance reinforces real demand, investors should maintain a balanced view — growth is strong, but it’s not without risks like supply chain bottlenecks, valuation, and geopolitical concerns.
Q2. How exactly will Indian semiconductor manufacturing benefit from Nvidia’s growth?
Higher global demand for AI chips strengthens the case for semiconductor investments in India. This could encourage more fabs, design centres, and collaborations if Indian policy and capital conditions align.
Q3. Should I invest in Nvidia directly or via Indian IT companies?
Both routes have merit. Direct exposure (NVDA shares) gives pure-play access, but investing in Indian IT companies offers leverage to India’s AI ecosystem growth, possibly with lower volatility and regulatory simplicity.
Q4. How does Swastika Investmart help in this context?
Swastika Investmart is SEBI-registered, offers powerful research tools, and supports international investing. Use its platform for guided insights, risk analysis, and thematic portfolios around AI/semiconductors.
Nvidia’s Q3 earnings are a resounding signal that AI infrastructure is accelerating, and the ripple effects could meaningfully shape the future of Indian technology markets. For Indian investors and corporations alike, this is more than just a U.S. company doing well — it’s an opportunity that aligns with India’s tech ambitions, semiconductor goals, and digital transformation journey.
If you’re looking to position yourself for this wave, Swastika Investmart offers the tools, trust, and technology to help you navigate global markets smartly. Open an account today and explore:

कमोडिटी फ्यूचर्स एक ऐसा डेरिवेटिव कॉन्ट्रैक्ट होता है, जिसमें आप किसी कमोडिटी (जैसे गोल्ड, क्रूड ऑयल, सिल्वर, या कॉपर) को भविष्य की तारीख पर तय कीमत पर खरीदने या बेचने का समझौता करते हैं।
उदाहरण के तौर पर —
अगर आप मानते हैं कि क्रूड ऑयल की कीमत बढ़ेगी, तो आप उसका फ्यूचर कॉन्ट्रैक्ट खरीदते हैं।
अगर कीमत बढ़ती है, तो आपको मुनाफा होता है; अगर गिरती है, तो नुकसान।
कमोडिटी ट्रेडिंग में सिर्फ कीमतें देखना पर्याप्त नहीं है।
डेटा एनालिसिस (OI, Volume, Rollover) से आप यह समझ सकते हैं कि —
इसलिए एक समझदार ट्रेडर के लिए फ्यूचर्स डेटा पढ़ना उतना ही ज़रूरी है जितना चार्ट देखना।
Open Interest (OI) बताता है कि किसी खास कमोडिटी फ्यूचर में कितने ओपन कॉन्ट्रैक्ट्स अभी तक क्लोज़ नहीं हुए हैं।
यह ट्रेंड की मजबूती और भागीदारी को दर्शाता है।
| प्राइस - OI - ट्रेंड की दिशा | ||
|---|---|---|
| प्राइस | OI | ट्रेंड की दिशा |
| बढ़ता हुआ | बढ़ता हुआ | Bullish (खरीदारी का दबाव) |
| घटता हुआ | घटता हुआ | Bearish (बेचने का दबाव) |
| प्राइस बढ़े | OI घटे | Short Covering |
| प्राइस घटे | OI बढ़े | Fresh Short Build-up |
हर फ्यूचर कॉन्ट्रैक्ट की एक एक्सपायरी डेट होती है (आमतौर पर महीने के आखिरी सप्ताह में)।
अगर ट्रेडर अपनी पोजीशन को अगले महीने के कॉन्ट्रैक्ट में शिफ्ट करता है, तो इसे Rollover कहा जाता है।
उदाहरण:
अगर सिल्वर में 85% Rollover दिख रहा है, तो इसका मतलब है कि ज़्यादातर ट्रेडर्स ने अपनी लंबी पोजीशन को अगले महीने तक बढ़ा लिया है — यानी सकारात्मक सेंटिमेंट जारी है।
ट्रेडिंग में सही निर्णय लेने के लिए आपको तीनों डेटा को एक साथ पढ़ना चाहिए।स्मार्ट ट्रेडिंग टिप:
सिर्फ प्राइस देखकर ट्रेड न करें — OI और Volume की पुष्टि ज़रूर करें।
| VOLUME - PRICE - OI INTERPRETATION | |||
|---|---|---|---|
| Volume | Price | OI | Interpretation |
| High | Up | Up | Strong Uptrend |
| High | Down | Up | Fresh Shorts |
| Low | Down | Down | Weak Downtrend |
| Low | Up | Down | Short Covering Rally |
अधिकांश ब्रोकर्स जैसे Swastika Investmart अपने ग्राहकों को Futures Analytics Tools प्रदान करते हैं।
इनसे आप रियल-टाइम OI, Rollover और Volume डेटा देख सकते हैं।
Swastika Investmart के प्लेटफॉर्म पर:
👉 यहाँ क्लिक करें और डेटा देखें
भारत का कमोडिटी डेरिवेटिव मार्केट (MCX, NCDEX) विश्व के सबसे तेज़ी से बढ़ते बाजारों में से एक है।
यहाँ गोल्ड, सिल्वर, क्रूड, कॉपर, और एग्री-कमोडिटीज़ में रोज़ाना अरबों रुपये का कारोबार होता है।
सरकार और SEBI के सख्त नियामक ढाँचे के कारण यह मार्केट अब पहले से कहीं ज़्यादा पारदर्शी और निवेशक-अनुकूल बन गया है।
Swastika Investmart एक SEBI-registered broker है, जो कमोडिटी, इक्विटी और डेरिवेटिव ट्रेडिंग में
अपने रिसर्च-बेस्ड एनालिटिक्स टूल्स और ग्राहक समर्थन के लिए प्रसिद्ध है।
Swastika के साथ आपको मिलता है:
👉 अभी खाता खोलें और डेटा-ड्रिवन ट्रेडिंग शुरू करें।
1️⃣ OI क्या दर्शाता है?
OI दिखाता है कि मार्केट में कितने ओपन कॉन्ट्रैक्ट्स हैं — यह भागीदारी और ट्रेंड की मजबूती बताता है।
2️⃣ Rollover कैसे समझें?
अगर ज़्यादातर ट्रेडर्स अपनी पोजीशन अगले महीने ले जा रहे हैं, तो Rollover हाई होता है — इसका मतलब है कि ट्रेंड में विश्वास बना हुआ है।
3️⃣ क्या OI डेटा रोज़ बदलता है?
हाँ, हर दिन जब भी नए कॉन्ट्रैक्ट्स जुड़ते या खत्म होते हैं, OI डेटा अपडेट होता है।
4️⃣ Futures Trading में यह डेटा क्यों ज़रूरी है?
क्योंकि यह बताता है कि “पैसा कहाँ जा रहा है” — यानी स्मार्ट मनी किस दिशा में ट्रेड कर रही है।
5️⃣ क्या मैं Swastika पर यह डेटा लाइव देख सकता हूँ?
हाँ, Swastika के डैशबोर्ड में रियल-टाइम OI, Volume और Rollover डेटा उपलब्ध है।
कमोडिटी फ्यूचर्स डेटा को समझना हर निवेशक और ट्रेडर के लिए एक महत्वपूर्ण स्किल है।
OI और Rollover से आप सिर्फ ट्रेंड नहीं, बल्कि मार्केट की गहराई और मूड समझ सकते हैं।
अगर आप डेटा-आधारित ट्रेडिंग सीखना चाहते हैं और बेहतर निर्णय लेना चाहते हैं — Swastika Investmart के साथ जुड़ें
The Sudeep Pharma IPO is among the most talked-about offerings this month, thanks to its strong financial performance and leadership position in pharma-grade minerals and excipients. With subscription dates 21–25 November 2025, investors are evaluating whether the steep valuation is justified by the company’s growth story.
This detailed analysis covers the company’s fundamentals, market position, valuations, strengths, risks, and whether retail investors should consider applying.
Founded in 1989, Sudeep Pharma has grown into one of India’s key manufacturers of pharmaceutical excipients and specialty chemicals, supplying more than 200+ products across pharma, food, and nutrition sectors. The company operates six manufacturing facilities with a combined capacity of 50,000 MT and serves several global blue-chip clients.
Their product portfolio includes:
Importantly, Sudeep Pharma holds prestigious global certifications such as US FDA, WHO-GMP, EXCiPACT, ISO 9001, FSSC 22000, HACCP, Kosher, and Halal, positioning the company as a trusted supplier in regulated markets.
In 2025, the company also acquired a European premix manufacturer (NSS), strengthening its foothold in the nutrition business.
Detail Information
Issue Size- ₹895 cr
Fresh Issue- ₹95 cr
OFS- ₹800 cr
Price Band- ₹563–593
Market Lot- 25 shares
Issue Dates- 21–25 Nov 2025
Post-issue Market Cap- ₹6,697.85 cr
Listing- BSE & NSE
The IPO consists largely of an Offer for Sale, meaning most proceeds go to existing shareholders, not the company. Only the fresh issue will fund capex for machinery at the Nandesari facility and general corporate expenses.
This is an impressive trend—both revenue and profitability have shown robust improvement. A near-40% EBITDA margin places Sudeep among the better-performing players in India’s specialty chemicals space.
Based on FY25 financials:
This valuation is on the higher side, even for high-quality pharma ingredient companies. The IPO note itself categorizes the issue as “aggressively priced”, indicating that most near-term growth is already factored into the pricing.
Not significantly. The valuation restricts the short-term upside. Investors looking for 10–20% short-term gains may find the risk-reward unfavourable.
If the company continues delivering:
then the valuation could still be justified over a multi-year horizon.
Manufacturing mineral-based excipients requires high R&D expertise, compliance systems, and technical know-how—creating strong entry barriers.
Sudeep Pharma Ltd. IPO note (1)
Sudeep serves several Fortune 500 and global blue-chip clients. Long-term contracts and consistent quality make the business sticky.
Regulated market approvals (e.g., US FDA, EXCiPACT) give the company a competitive advantage, especially in the pharma excipients space.
Multiple in-house labs, pilot plants, and a team dedicated to mineral salts innovation drive product development.
Even strong companies carry risks. For Sudeep Pharma, key concerns include:
This increases vulnerability to client or segment-level slowdowns.
All manufacturing facilities are located in Gujarat, exposing operations to regional disruptions.
Failure to pass audits from global pharma clients could lead to immediate order loss.
4. M&A Integration Risk
Integrating NSS or future acquisitions may strain resources or fail to deliver expected synergies.
The fundamentals are strong: high margins, diversified products, global certifications, and solid financial growth. However, valuation is steep, reducing the probability of short-term listing gains.
The IPO opens on 21 November 2025 and closes on 25 November 2025.
The price band is ₹563–593 per share.
The IPO is aggressively priced, leaving limited room for short-term gains. Suitable mainly for long-term investors.
Primarily for capex—procurement of machinery for the Nandesari facility—and general corporate purposes.
No direct listed peers exist in India in the same line of business.
Invest in upcoming IPOs, equities, and mutual funds with a trusted SEBI-registered broker. Swastika Investmart offers powerful research tools, strong customer support, and a seamless tech-enabled platform.


Trust Our Expert Picks
for Your Investments!



